Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Josef Scheiber

1-17 of 17 results

Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure

scientific article (publication date: June 2007)

How similar are similarity searching methods? A principal component analysis of molecular descriptor space

scientific article published in January 2009

Mapping adverse drug reactions in chemical space.

scientific article

Gaining insight into off-target mediated effects of drug candidates with a comprehensive systems chemical biology analysis.

scientific article

Targeting acetylcholinesterase to treat neurodegeneration

scientific article published on February 2007

Aziridide-Based Inhibitors of Cathepsin L: Synthesis, Inhibition Activity, and Docking Studies

scientific article published on 01 October 2006

Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity

scientific article published on 16 June 2009

Charge interactions do the job: a combined statistical and combinatorial approach to finding artificial receptors for binding tetrapeptides in water

scientific article published in November 2005

Interaction of (benzylidene-hydrazono)-1,4-dihydropyridines with beta-amyloid, acetylcholine, and butyrylcholine esterases

scientific article published on 15 January 2010

Use of ligand based models for protein domains to predict novel molecular targets and applications to triage affinity chromatography data

scientific article

"Virtual fragment linking": an approach to identify potent binders from low affinity fragment hits

scientific article

xMaP-An Interpretable Alignment-Free Four-Dimensional Quantitative Structure-Activity Relationship Technique Based on Molecular Surface Properties and Conformer Ensembles

scientific article published on 27 November 2017

Chemogenomic analysis of safety profiling data

scientific article published in January 2009

Cis-Configured aziridines are new pseudo-irreversible dual-mode inhibitors of Candida albicans secreted aspartic protease 2.

scientific article published in February 2008

Side effect profile prediction - early addressing of big pharma's worst nightmare

scientific article

How can we enable drug discovery informatics for personalized healthcare?

scientific article

Backtranslating clinical knowledge for use in cheminformatics--what is the potential?

scientific article